Development of a novel antibody-drug conjugate targeting both CEACAM5 and CEACAM6. (October 2022) - Arias, K.; Enos, C.; Spear, M.; Austin, D.; Almofeez, R.; Kortchak, S.; Pincus, L.; Kwon, Y.; Gelber, C.